Last reviewed · How we verify
Benefit of IQP-AS-118 on Blood Pressure and LDL-cholesterol
The purpose of this study is to evaluate the benefit and tolerability of IQP-AS-118 on the systolic and diastolic blood pressure (BP) and to explore the effects on parameters of lipid metabolism in subjects with elevated BP and low density lipoprotein cholesterol (LDL-C) levels in a pilot study.
Details
| Lead sponsor | InQpharm Group |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 54 |
| Start date | Fri Mar 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Blood Pressure
- Low Density Lipoprotein Cholesterol Level
Interventions
- IQP-AS-118
- Placebo
Countries
Germany